Facilitated By

San Antonio Medical Foundation

News

  • Enanta Pharmaceuticals: Fiscal Q4 Earnings Snapshot - San Antonio Express-News

    The biotechnology company posted revenue of $14.6 million in the ... The San Antonio-based grocer intends to build a supermarket with True ...

  • Olema Oncology to Present New Data Combining Palazestrant with Ribociclib at the San ...

    ... San Antonio Breast Cancer Symposium. 11/25/24 5:30:00 PM ET. $OLMA. Biotechnology: Pharmaceutical Preparations. Health Care. Get the next $OLMA alert ...

  • Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 San Antonio ...

    ... San Antonio Breast Cancer Symposium (SABCS), being held December 10 ... Arvinas (Nasdaq: ARVN) is a clinical-stage biotechnology company ...

  • Olema Oncology to Present New Data Combining Palazestrant with Ribociclib at the San Antonio

    ... San Antonio Breast Cancer Symposium (SABCS 2024) being held December 10 ... Tags. Biotech · Clinical Trials · Olma · Breast Cancer · Health ...

  • Arvinas to Present New Vepdegestrant Breast Cancer Treatment Data at SABCS 2024

    ... San Antonio Breast Cancer Symposium (SABCS), being held December 10-13 ... Arvinas (Nasdaq: ARVN) is a clinical-stage biotechnology company ...